CLN11 disease

CLN11 disease, also known as neuronal ceroid lipofuscinosis type 11 (NCL11), is an extremely rare inherited brain disorder that belongs to a group of conditions called neuronal ceroid lipofuscinoses (NCLs), sometimes referred to as Batten disease. In CLN11 disease, the body cannot properly break down certain fatty substances (lipopigments) inside cells, causing them to build up and damage nerve cells in the brain and other parts of the body over time. The disease is caused by mutations in the GRN gene (also known as the progranulin gene), which provides instructions for making a protein involved in cell survival and waste cleanup within cells. When this protein does not work correctly, toxic materials accumulate inside cells, particularly in the brain and the eyes. This leads to progressive neurological decline. Key symptoms typically include seizures, vision loss, problems with movement and coordination, and a decline in thinking and memory skills. The disease tends to appear in early adulthood, though the exact age of onset can vary. Because CLN11 disease is so rare, there are currently no specific approved treatments that can cure or halt the disease. Management focuses on controlling seizures, supporting vision, and providing physical and occupational therapy to maintain quality of life for as long as possible. Research into potential therapies, including gene therapy and enzyme replacement approaches, is ongoing for the broader group of NCL disorders.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Bring these to your next appointment

• Q1.What is the expected rate of progression for my specific case of CLN11 disease?,Which anti-seizure medications are best suited for my type of seizures, and what side effects should I watch for?,Are there any clinical trials or experimental treatments I might be eligible for?,How often should I have brain imaging, eye exams, and neuropsychological testing to monitor the disease?,Should my family members be tested for the GRN gene mutation?,What therapies (physical, occupational, speech) would benefit me most right now?,What support services and resources are available for me and my family as the disease progresses?

Common questions about CLN11 disease